Atiratecan

Overview

Atiratecan (TP300) is a proagent of camptothecin analog CH0793076 ( HY-107096 ). Atiratecan does not inhibit acetylcholinesterase ( AChE ) activities. Atiratecan shows antitumor activity against both breast cancer resistance protein ( BCRP )-positive and -negative xenografts in mouse xenograft models.

Application

Products | Products > Signaling Pathways > Cell Cycle/DNA Damage | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Immunotherapy | Products > Research Areas > Cancer > Cancer Drug Resistance | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Signaling Pathways > Topoisomerase

Product Information

• Catalog No.: HY-14833
• CAS No.: 867063-97-6
• Molecular Formula: C31H34N6O6
• Molecular Weight: 586.64
• Purity: 99.98%
• Storage: Please store the product under the recommended conditions in the Certificate of Analysis.

Source

Original product source